NeoSENTIA NIPD Genetics Liquid Biopsy Cancer Logo (WIPO, 06/08/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark NeoSENTIA NIPD Genetics Liquid Biopsy Cancer was filed as Figurative mark on 06/08/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Series of letters in different dimensions #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1545721 |
| Register number | 018191806 |
| Countries | 
|
| Base trademark |
No. 018191806,
May 29, 2020
|
| Application date | June 8, 2020 |
| Expiration date | June 8, 2030 |
Trademark owner
31, Neas Engomis, Engomi
2409 Nicosia
CY
2409 Nicosia
CY
Trademark representatives
2-4, Arch. Makaros III Avenue,
Capital Center, 7th floor
CY
goods and services
01
Kits composed of reagents for genetic testing for medical
and scientific research purposes; kits composed of reagents
for genetic testing for medical and scientific research
purposes in the field of oncology; kits composed of reagents
for cancer diagnosis and prognosis for medical and
scientific research purposes; kits composed of reagents for
testing for chromosomal or mutational abnormalities in
cancer patients for medical and scientific research
purposes
42
Medical laboratory services for cancer testing; design and
development of medical diagnostic tests and products;
medical and scientific research in the field of genetic
testing particularly in the field of oncology; providing
medical and scientific research information in the field of
genetic testing; genetic testing for scientific research and
analysis purposes in the field of oncology cancer; genetic
engineering services
44
Medical testing services for diagnosis of cancer; medical
genetic screening testing; medical diagnostic testing in the
field of oncology; medical testing of blood for diagnosis of
genetic abnormalities such as mutations during cancer
disease; medical testing for diagnosis of genetic disorders,
diseases and syndromes; genetic testing and genetic
counseling in the field of cancer treatment; medical and
health services relating to DNA, genetics and genetic
testing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 27, 2022 | 2022/5 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 5, 2021 | 2021/31 Gaz | JP | Rejection |
| July 29, 2021 | 2021/30 Gaz | UA | Rejection |
| June 30, 2021 | 2021/30 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 5, 2021 | 2021/10 Gaz | IL | Rejection |
| March 1, 2021 | 2021/9 Gaz | IN | Rejection |
| February 8, 2021 | 2021/6 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 5, 2021 | 2021/6 Gaz | SG | Rejection |
| February 4, 2021 | 2021/6 Gaz | RS | Rejection |
| December 23, 2020 | 2020/53 Gaz | TR | Rejection |
| December 1, 2020 | 2020/50 Gaz | RU | Rejection |
| October 1, 2020 | 2020/40 Gaz | US | Rejection |
| June 8, 2020 | 2020/31 Gaz | EM | Registration |
ID: 141545721